Careers Contact Us
Facebook Twitter LinkedIn
logo_abeona_retina
  • Home
  • About
    • Mission
    • Leaders
  • Science
    • Pipeline
    • Manufacturing
    • The AIMTM Vector
  • Clinical Trials
    • Overview
    • Recessive Dystrophic Epidermolysis Bullosa (RDEB)
  • Patients & Families
    • Patient Advocacy & Community Engagement (PACE)
    • Our Focus
    • Resources
    • Our Inspiration
    • Access Policy
  • Investors & Media
    • Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Careers
  • Contact Us
×
  • Home
  • About
    • Mission
    • Leaders
  • Science
    • Pipeline
    • Manufacturing
    • The AIMTM Vector
  • Clinical Trials
    • Overview
    • Recessive Dystrophic Epidermolysis Bullosa (RDEB)
  • Patients & Families
    • Patient Advocacy & Community Engagement (PACE)
    • Our Focus
    • Resources
    • Our Inspiration
    • Access Policy
  • Investors & Media
    • Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Careers
  • Contact Us

Press Releases

Investors

Investors & Media

  • Overview
  • News / Events
    • Overview
    • Press Releases
    • Events
    • Email Alerts
  • Company Info
    • Overview
    • Profile
    • Presentations
    • Management Team
    • Scientific Advisory Board
    • Contacts
  • Financial Info
    • Overview
    • Financial Results
  • Stock Data
    • Overview
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed
  • News / Events

  • Overview
  • Press Releases
  • Events
  • Email Alerts

Abeona Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results

Mar 18, 2019

Abeona Therapeutics Announces Participation in 8th Annual SVB Leerink Global Healthcare Conference

Feb 22, 2019

Abeona Therapeutics Appoints João Siffert, M.D. Chief Executive Officer

Feb 11, 2019

Abeona Therapeutics to Present New Supportive Data for Novel Gene Therapies at WORLDSymposium™

Jan 31, 2019

Abeona Therapeutics Strengthens Financial Leadership with New Executive Appointments

Jan 8, 2019

Abeona Therapeutics Details Pathway for Advancing Lead Clinical Programs and Unveils New Cystic Fibrosis Program Born from Next Generation AIM™ Vector Platform at 2018 R&D Day

Dec 6, 2018

Abeona Therapeutics to Host R&D Day on December 6, 2018

Nov 29, 2018

Abeona Therapeutics Announces CEO Transition

Nov 26, 2018

Abeona Announces Participation at the Jefferies 2018 London Healthcare Conference

Nov 13, 2018

Abeona Therapeutics Reports Third Quarter 2018 Financial Results and Business Highlights

Nov 9, 2018
RSS
    • 1...
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14
    • 15
    • ...25

    © 2023 Abeona Therapeutics Inc. All Rights Reserved. | Privacy Policy